A recent study from Brazil has suggested that vitamin D supplementation may enhance the effectiveness of chemotherapy in women diagnosed with breast cancer. Conducted by researchers at the Botucatu School of Medicine, São Paulo State University, the study involved 80 women over the age of 45 who were about to begin neoadjuvant chemotherapy, a treatment used to shrink tumors before surgical intervention.
Participants were divided into two groups: one received a daily supplement of 2,000 international units (IU) of vitamin D, while the other was given a placebo. After six months, results indicated that 43% of those taking vitamin D experienced complete cancer disappearance compared to only 24% in the placebo group. Eduardo Carvalho-Pessoa, a co-author of the study published in the journal Nutrition and Cancer, noted that the dosage used was much lower than typical therapeutic levels for correcting deficiency.
Vitamin D is primarily recognized for its role in bone health but has also been implicated in immune function, which may contribute to its potential benefits in cancer treatment. Most study participants began with vitamin D levels considered deficient, highlighting a common health issue. The study suggests that supplementation could be a cost-effective alternative to more expensive treatments designed to enhance chemotherapy response.
While the findings are promising, the researchers emphasize the need for larger studies to further assess the efficacy of vitamin D in this context. They advocate for additional research to better understand its role in improving chemotherapy outcomes and the potential for increased breast cancer remission rates.